Drugs of Today 2007-07-01

Rufinamide.

D Heaney, M C Walker

Index: Drugs Today (Barc) 43(7) , 455-60, (2007)

Full Text: HTML

Abstract

Rufinamide is a new antiepileptic drug that is effective in acute animal seizure models and also in the kindling model of epilepsy with a high protective index. Its mechanism of action is largely unknown; studies suggest an effect at voltage-gated sodium channels, but whether this is its main mode of action remains to be determined. Rufinamide can be administered twice daily and has minimal drug interactions (it does, however, interact with the contraceptive pill). Food markedly increases absorption, which may complicate clinical use. Trials indicate that rufinamide is effective as adjunctive therapy in partial epilepsy and the Lennox-Gastaut syndrome with minimal adverse effects including headache, dizziness and fatigue. In addition, rufinamide has a favorable cognitive side-effect profile. However, it remains uncertain whether rufinamide offers significant advantages over other current antiepileptic drugs, and the results of further clinical trials are awaited.

Related Compounds

  • Rufinamide

Related Articles:

Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats.

2015-02-20

[Eur. J. Pharm. Sci. 68 , 106-13, (2015)]

Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of basic drugs and metabolites.

2015-06-01

[Biomed. Chromatogr. 29 , 935-52, (2015)]

Rufinamide for the treatment of Lennox-Gastaut syndrome.

2011-04-01

[Expert Opin. Pharmacother. 12(5) , 801-6, (2011)]

Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.

2011-03-01

[Epileptic Disord. 13(1) , 18-21, (2011)]

Bioavailability of three rufinamide oral suspensions compared with the marketed 400-mg tablet formulation: results from a randomized-sequence, open-label, four-period, four-sequence crossover study in healthy subjects.

2011-01-01

[Clin. Ther. 33(1) , 146-57, (2011)]

More Articles...